End
1 :

Today, 0830:

Client presents to the clinic for the management of hypertension and review of laboratory tests obtained 3 days before this visit. Client has a history of hypertension and asthma. Client is currently taking lisinopril 5 mg PO daily.

Today, 0845:

Client is alert and oriented to person, place, time, and situation. Respirations are even and nonlabored. Scattered wheezes auscultated in bilateral anterior lung fields. Vital signs were obtained.

Today, 0900:

Provider in to examine client. A new prescription has been received. Nurse to provide education to the client about new prescription.

3 days ago:

Hemoglobin 11 g/dL (12 to 16 g/dL)

Hematocrit 46% (37% to 47%)

Sodium 130 mEq/L (1 36 to 145 mEq/L)

Potassium 5.6 mEq/L (3.5 to 5 mEq/L)

BUN 30 mg/dL (10 to 20 mg/dL)

Creatine 3 mg/dL (0.5 to 1 mg/dL)

Today, 0900:

Spironolactone 25 mg PO twice daily

Today, 0845:

Temperature 37.1°C (98.8°F)

Heart rate 90/min

Respiratory rate 20/min

Blood pressure 150/70 mm Hg

Oxygen saturation 97% on room air


Click to highlight the client’s findings that are a potential contraindication to the client's new prescription and the nurse should report to the provider. To deselect a finding click on the finding again.


Nurses' Notes Today, 0830: Client presents to the clinic for the management of hypertension and review of laboratory tests obtained 3 days before this visit. Client has a history of hypertension and asthma. Client is currently taking lisinopril 5 mg PO daily. Today, 0845: Client is alert and oriented to person, place, time, and situation. Respirations are even and nonlabored. Scattered wheezes auscultated in bilateral anterior lung fields. Vital signs were obtained. Today, 0900: Provider in to examine client. A new prescription has been received. Nurse to provide education to the client about new prescription. Vital Signs  Today, 0845: Temperature 37.1°C (98.8°F) Heart rate 90/min Respiratory rate 20/min Blood pressure 150/70 mm Hg Oxygen saturation 97% on room air Laboratory Results 3 days ago: Hemoglobin 11 g/dL (12 to 16 g/dL) Hematocrit 46% (37% to 47%) Sodium 130 mEq/L (1 36 to 145 mEq/L) Potassium 5.6 mEq/L (3.5 to 5 mEq/L) BUN 30 mg/dL (10 to 20 mg/dL) Creatine 3 mg/dL (0.5 to 1 mg/dL)


Hint : 🍌Spironolactone saves potassium.

Correct Highlights :
  • Client is currently taking lisinopril 5 mg PO daily.
  • Potassium 5.6 mEq/L (3.5 to 5 mEq/L)
  • BUN 30 mg/dL (10 to 20 mg/dL)
  • Creatine 3 mg/dL (0.5 to 1 mg/dL)

Rationale :

Current lisinopril use

🟢 The client is already taking lisinopril, which is an ACE inhibitor.

🟢ACE inhibitors can increase serum potassium by decreasing aldosterone effects.

🟢Spironolactone is a potassium-sparing diuretic, so combining it with lisinopril increases the risk for dangerous hyperkalemia.

🟢Hyperkalemia can cause cardiac dysrhythmias, muscle weakness, and cardiac arrest if severe.

🟢The nurse should report this medication combination to the provider before teaching or administering the new prescription.

Potassium 5.6 mEq/L

🟢 A potassium level of 5.6 mEq/L is elevated above the normal range.

🟢 Spironolactone can further increase potassium because it prevents potassium loss in the urine.

🟢 Giving spironolactone to a client who already has hyperkalemia can worsen the potassium elevation.

🟢 Elevated potassium is especially dangerous because it can affect cardiac conduction.

🟢 This finding is a major contraindication and must be reported to the provider.

BUN 30 mg/dL

🟢A BUN of 30 mg/dL is elevated and suggests impaired kidney function or decreased renal perfusion.

🟢Kidney impairment reduces the body’s ability to regulate potassium and eliminate medications effectively.

🟢Spironolactone use in renal impairment increases the risk for hyperkalemia and medication accumulation.

🟢This finding is concerning when combined with elevated creatinine and high potassium.

🟢The nurse should report the abnormal renal value before the client starts spironolactone.

Creatinine 3 mg/dL

🟢A creatinine level of 3 mg/dL is significantly elevated and indicates impaired renal function.

🟢Spironolactone should be used cautiously or avoided in clients with significant renal impairment.

🟢Poor kidney function increases the risk for potassium retention, especially with potassium-sparing medications.

🟢This client already has hyperkalemia, making the renal impairment even more concerning.

🟢The nurse should notify the provider because spironolactone could worsen electrolyte imbalance and cause serious complications.


Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

QLexNursing Calculator Click & Drag ×
AC
(
)
CE
π
e
φ
τ
Inv
sin-1
cos-1
tan-1
log
ln
!
deg
√
x²
x³
^
7
8
9
÷
4
5
6
×
1
2
3
-
0
.
exp
+
Rnd
Ans
=